Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS-CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice.

IMPORTANCE: The development of safe and effective vaccines is needed to control the transmission of coronavirus disease 2019 (COVID-19). Synthetic DNA vaccines represent a promising platform in response to such outbreaks. Here, DNA vaccine candidates were developed using an optimized antibiotic-resistance gene-free asd-pVAX1 vector. An optimized flagellin (FliC) adjuvant was designed by fusion expression to increase the immunogenicity of the S1 antigen. S1 and S1-FliCΔD2D3 proteins were strongly expressed in mammalian cells. The FliCΔD2D3-adjuvanted DNA vaccine induced Th1/Th2-mixed immune responses and high titers of neutralizing antibodies. This study provides crucial information regarding the selection of a safer DNA vector and adjuvant for vaccine development. Our FliCΔD2D3-adjuvanted S1 DNA vaccine is more potent at inducing both humoral and cellular immune responses than S1 alone. This finding provides a new idea for the development of novel DNA vaccines against COVID-19 and could be further applied for the development of other vaccines.

Peroxymonosulfate Activation by Fe(III)-Picolinate Complexes for Efficient Water Treatment at Circumneutral pH: Fe(III)/Fe(IV) Cycle and Generation of Oxyl Radicals.

Improving the reactivity of Fe(III) for activating peroxymonosulfate (PMS) at circumneutral pH is critical to propel the iron-activated PMS processes toward practical wastewater treatment but is yet challenging. Here we employed the complexes of Fe(III) with the biodegradable picolinic acid (PICA) to activate PMS for degradation of selected chlorinated phenols, antibiotics, pharmaceuticals, herbicides, and industrial compounds at pH 4.0-6.0. The FeIII-PICA complexes greatly outperformed the ligand-free Fe(III) and other Fe(III) complexes of common aminopolycarboxylate ligands. In the main activation pathway, the key intermediate is a peroxymonosulfate complex, tentatively identified as PICA-FeIII-OOSO3-, which undergoes O-O homolysis or reacts with FeIII-PICA and PMS to yield FeIV=O and SO4•- without the involvement of commonly invoked Fe(II). PICA-FeIII-OOSO3- can also react directly with certain compounds (chlorophenols and sulfamethoxazole). The relative contributions of PICA-FeIII-OOSO3-, FeIV=O, and SO4•- depend on the structure of target compounds. This work sets an eligible example to enhance the reactivity of Fe(III) toward PMS activation by ligands and sheds light on the previously unrecognized role of the metal-PMS complexes in directing the catalytic cycle and decontamination as well.